FDA Confirms Direct Review Path For Aquestive’s Allergy Treatment
The U.S. Food and Drug Administration (FDA) on Thursday informed Aquestive Therapeutics, Inc. (NASDAQ:AQST) that an advisory committee…
Browsing Tag
target action
1 post